The changes of circulating tumor cells by stereotactic radiotherapy for huge tumor due to telomesca
Not Applicable
Recruiting
- Conditions
- malignancy
- Registration Number
- JPRN-UMIN000013500
- Lead Sponsor
- Tokyo Radiation Oncology Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
No indication for stereotactic radiotherapy No agreement with test of telomescan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy
- Secondary Outcome Measures
Name Time Method